- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 15, 2026 | 49.1M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 49.2M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 49.2M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $17.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $2.4M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $2.5M |
| Capex | Q1 2026 · Mar 31, 2026 | $43.5M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $33M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $71.9M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$700K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $153.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $214.6M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.65B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.64B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.45B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.43B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $489.6M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $503.7M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.35B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.34B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.13B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.11B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.99B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.77 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.48 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.77 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.48 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $75.8M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $71M |
| Net Income | Q1 2026 · Mar 31, 2026 | $37.8M |
| Net Income | Q1 2026 · Mar 31, 2025 | $23.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $47.1M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $41M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $120.9M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $107.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $450.8M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $439.7M |
| Revenue | Q1 2026 · Mar 31, 2026 | $571.7M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $547.6M |